ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

PVCT Provectus Biopharmaceuticals Inc (QB)

0.19305
0.00175 (0.91%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Provectus Biopharmaceuticals Inc (QB) USOTC:PVCT OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00175 0.91% 0.19305 0.0001 0.199 0.198 0.1901 0.198 128,865 21:15:26

Amended Statement of Beneficial Ownership (3/a)

25/11/2020 6:09pm

Edgar (US Regulatory)


FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Horowitz Bruce
2. Date of Event Requiring Statement (MM/DD/YYYY)
4/3/2017 

3. Issuer Name and Ticker or Trading Symbol

PROVECTUS BIOPHARMACEUTICALS, INC. [PVCT]
(Last)        (First)        (Middle)

10025 INVESTMENT DRIVE, SUITE 250
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                          _____ 10% Owner
_____ Officer (give title below)        _____ Other (specify below)
(Street)

KNOXVILLE, TN 37932      

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
4/13/2017 

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 1827243 (1)D  

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares

Explanation of Responses:
(1) This amendment is being filed to report 435,000 shares of common stock held by the reporting person that were inadvertently omitted from his Form 3.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Horowitz Bruce
10025 INVESTMENT DRIVE
SUITE 250
KNOXVILLE, TN 37932
X



Signatures
/s/ Bruce Horowitz11/25/2020
**Signature of Reporting PersonDate

1 Year Provectus Biopharmaceuti... (QB) Chart

1 Year Provectus Biopharmaceuti... (QB) Chart

1 Month Provectus Biopharmaceuti... (QB) Chart

1 Month Provectus Biopharmaceuti... (QB) Chart

Your Recent History

Delayed Upgrade Clock